Skip to main content

and
  1. Article

    Open Access

    Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia

    The aim of this study was to investigate the effect of recombinant human endostatin (rh-Endo) in combination with radiation therapy (RT) on esophageal squamous cell carcinoma (ESCC) and explore the potential m...

    Hongcheng Zhu, ** Yang, Yuqiong Ding, Jia Liu, **g Lu in Scientific Reports (2015)